Mark I L Watling
Mark I L Watling publishes mostly in Physiology, Psychiatry and Mental health and Pharmacology, on topics such as Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases and Dementia and Cognitive Impairment Research.
- World rank
- #757,449 of 7,710,434 ranked researchers
- Rank in Italy
- #22,773 of 242,206
- Works
- 36
- Citations
- 1.9k
- Citations per work
- 53.2
What does Mark I L Watling research?
Mark I L Watling's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (7%), Pharmacology, Toxicology and Pharmaceutics (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1645.3%
- Medicine1645.3%
- Everything else1542.4%
- Life Sciences412.3%
- 1Physiology18% of their works
- 2Psychiatry and Mental health12% of their works
- 3Pharmacology9% of their works
- 4Molecular Biology7% of their works
- 5Pharmaceutical Science6% of their works
- 6Neurology6% of their works
Research topics
- Alzheimer's disease research and treatments
- Cholinesterase and Neurodegenerative Diseases
- Dementia and Cognitive Impairment Research
- Advanced Drug Delivery Systems
- Pain Management and Opioid Use
- Psoriasis: Treatment and Pathogenesis
- Neuroinflammation and Neurodegeneration Mechanisms
- Computational Drug Discovery Methods
Which keywords describe Mark I L Watling's research?
The keywords of their largest research topics: Neurodegeneration, Neuroinflammation, Alzheimer's Disease, Amyloid Hypothesis, Tau Pathology, Acetylcholinesterase, Cholinesterase Inhibitors and Dementia.
- Molecular Docking
- Astrocytes
- IL-17
- Nanoparticles
- Cancer Pain
- Dementia
- Acetylcholinesterase
- Amyloid Hypothesis
- Neuroinflammation
- Neurodegeneration
- Alzheimer's Disease
- Tau Pathology
- Cholinesterase Inhibitors
- Mild Cognitive Impairment
- Chitosan
- Pain Management
- TH17 Cells
- Microglia
- Virtual Screening
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Neurodegeneration222 topics
- Neuroinflammation222 topics
- Alzheimer's Disease192 topics
- Amyloid Hypothesis191 topic
- Tau Pathology191 topic
- Acetylcholinesterase101 topic
- Cholinesterase Inhibitors101 topic
- Dementia91 topic
- Mild Cognitive Impairment91 topic
- Cancer Pain51 topic
- Chitosan51 topic
- Nanoparticles51 topic
- Pain Management51 topic
- IL-1741 topic
- TH17 Cells41 topic
- Astrocytes31 topic
- Microglia31 topic
- Molecular Docking31 topic
- Virtual Screening31 topic
Where does Mark I L Watling work?
Mark I L Watling's main affiliation in the publication record is Chiesi (Italy), Italy.
How many publications and citations does Mark I L Watling have?
OpenAlex counts 36 works and 1,915 citations for Mark I L Watling, an h-index of 21, ranking #757,449 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mark I L Watling. Posts are plain text and can be reported.